|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
|
|---|---|---|---|
| Operating expenses: | |||
| Research and development | |||
| General and administrative | |||
| Acquired in-process research and development | |||
| Total operating expenses | |||
| Loss from operations | |||
| Other income (expense): | |||
| Interest income | |||
| Interest expense | |||
| Other expense, net | |||
| Total other income | |||
| Net loss before income taxes | |||
| Provision for income taxes | |||
| Net loss | |||
| Other comprehensive loss: | |||
| Unrealized gain (loss) on marketable securities | |||
| Comprehensive loss | |||
| Net loss per share, basic | |||
| Net loss per share, diluted | |||
| Weighted-average shares outstanding, basic | |||
| Weighted-average shares outstanding, diluted |
Loading...